Reference health

Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids

https://doi.org/10.1038/npjamd.2016.12
CiteStamped reference-health badge
48/48 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 48 checked references that resolve
resolves10.1021/cn500051h
Back to the Future with Phenotypic Screening
resolves10.4161/auto.5269
Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila
resolves10.1523/JNEUROSCI.2775-12.2012
The β-Secretase-Derived C-Terminal Fragment of βAPP, C99, But Not Aβ, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus
resolves10.1523/JNEUROSCI.3383-10.2010
Effects of Synaptic Modulation on β-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice
resolves10.1016/S0304-3940(01)01876-6
Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice
resolves10.1016/j.neuron.2005.01.040
Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice
resolves10.1016/j.neurobiolaging.2005.05.022
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
resolves10.1523/JNEUROSCI.1370-04.2004
Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
resolves10.1038/nature02998
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
resolves10.1172/JCI58644
Innate immunity in the central nervous system
resolves10.1016/0169-328X(94)90092-2
Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein
resolves10.1038/sj.cdd.4401646
Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli
resolves10.1523/JNEUROSCI.5183-12.2013
Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
resolves10.2174/1381612033455332
Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding
resolves10.1038/cddis.2012.86
Caspase-1: is IL-1 just the tip of the ICEberg?
resolves10.1038/nrd1225
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
resolves10.1016/j.tibs.2007.06.002
5-Lipoxygenase: regulation of expression and enzyme activity
resolves10.1016/j.neuroscience.2010.09.019
5-Lipoxygenase in mouse cerebellar Purkinje cells
resolves10.1016/j.bbalip.2010.05.013
Phospholipase A2 and arachidonic acid in Alzheimer's disease
resolves10.1038/nn.2213
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
resolves10.1007/BF01972714
Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2
resolves10.1523/JNEUROSCI.23-10-04127.2003
Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against<i>In Vivo</i>Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases
resolves10.1016/j.redox.2013.12.016
Role of advanced glycation end products in cellular signaling
resolves10.1371/journal.pone.0059586
Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease
resolves10.18632/aging.100531
The role of inflammation in age-related disease
resolves10.1100/2012/756357
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
resolves10.1016/j.neuron.2013.04.005
Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
resolves10.1016/S0896-6273(02)00794-8
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
resolves10.1016/j.neurobiolaging.2014.03.026
Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
resolves10.1212/WNL.59.6.880
Reduced incidence of AD with NSAID but not H<sub>2</sub>receptor antagonists
resolves10.1001/jama.289.21.2819
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression
resolves10.1007/s11357-010-9135-y
Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice
resolves10.1006/bbrc.1998.9981
Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
resolves10.1111/j.1460-9568.2007.05627.x
PGD<sub>2</sub> DP1 receptor protects brain from ischemia‐reperfusion injury
resolves10.1016/0197-0186(94)90118-X
Protection by prostaglandins from glutamate toxicity in cortical neurons☆
resolves10.1002/jnr.10373
Neuroprotective effects of prostaglandin E<sub>2</sub> or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation
resolves10.1523/JNEUROSCI.4485-03.2004
Neuroprotective Function of the PGE<sub>2</sub>EP2 Receptor in Cerebral Ischemia
resolves10.1016/j.neurobiolaging.2014.05.016
Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice
resolves10.1111/acel.12185
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in <scp>A</scp>lzheimer's disease transgenic mice
resolves10.1016/j.cell.2010.01.022
Pattern Recognition Receptors and Inflammation
resolves10.1002/hep.25572
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
resolves10.1002/glia.20983
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
resolves10.1038/nn.4086
Mechanisms of stress in the brain
resolves10.1038/sj.bjp.0707446
Alzheimer's disease; taking the edge off with cannabinoids?
resolves10.1186/1742-2094-9-8
Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
resolves10.1016/j.nbd.2004.04.001
A cell-based screen for drugs to treat Huntington's disease
resolves10.1208/s12248-009-9084-5
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
resolves10.1189/jlb.3RU0115-021R
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
The 2 references without a DOI — listed, not checked
no DOI — not checkedBayer, T. A. & Wirths, O. Intracellular accumulation of amyloid-Beta—a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front. Aging Neurosci. 2, 8 (2010).
no DOI — not checkedOlgiati, P., Politis, A. M., Papadimitriou, G. N., De Ronchi, D. & Serretti, A. Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways. Int. J. Alzheimers Dis. 2011, 832379 (2011).
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/npjamd.2016.12"><img src="https://citestamp.com/citestamped/10.1038/npjamd.2016.12/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/npjamd.2016.12/badge.svg)](https://citestamp.com/citestamped/10.1038/npjamd.2016.12)